A Pilot Study to Evaluate the Safety and Efficacy of Amniotic Membrane Transplantation in Patients with Arthrofibrosis following Total Knee Arthroplasty
IRB Number: 2015-069
not enrolling new patientsAugust 18, 2014
Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Principal Investigator
Co-Investigators
- Seth A. Jerabek, MD
- Kaitlin M. Carroll
Summary
5 patients, and 6 month’s post operatively for follow-up.
Inclusion/Exclusion Criteria
- Inclusion Criteria: (1) Patients with mature arthrofibrosis who are a minimum of 1 year post TKA and (2) Documented flexion less than 90 degrees.
- Exclusion Criteria: Patients that are wheelchair bound.
Contact Information
David J. Mayman, MD
maymand@hss.edu
212.774.2024